Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Melanoma 147Carcinoma, Non-Small-Cell Lung 34Skin Neoplasms 28Colorectal Neoplasms 28Breast Neoplasms 25Lung Neoplasms 24Carcinoma, Renal Cell 21Ovarian Neoplasms 20Neoplasms 20Squamous Cell Carcinoma of Head and Neck 19Carcinoma, Basal Cell 19Carcinoma, Merkel Cell 18Sarcoma 17Prostatic Neoplasms 17Pancreatic Neoplasms 16Neoplasm Metastasis 15Head and Neck Neoplasms 14Stomach Neoplasms 13Thyroid Neoplasms 12Uterine Cervical Neoplasms 11Urinary Bladder Neoplasms 11Carcinoma, Hepatocellular 11Lymphoma, T-Cell, Cutaneous 10Esophageal Neoplasms 10Carcinoma, Transitional Cell 9Uveal Melanoma 8Triple Negative Breast Neoplasms 8Mycosis Fungoides 8Colonic Neoplasms 8Small Cell Lung Carcinoma 7

Interventions

tirbanibulin 1Cryotherapy 1BF-200 ALA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Keratosis, Actinic × Dermatologic × 30 days × Clear all
NCT05662202 2026-05-22

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Biofrontera Inc.

Phase 3 Active not recruiting
172 enrolled
Dermatologic

Keratosis, Actinic

NCT07273656 2026-05-22

TIRBACRYO

University Hospital, Lille

Phase 3 Not yet recruiting
59 enrolled
Dermatologic

Keratosis, Keratosis, Actinic

NCT05212246 2026-05-08

B3C

VA Office of Research and Development

Phase 3 Not yet recruiting
1,630 enrolled
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Patient Compliance, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡